Mifepristone Treatment Promotes Testicular Leydig Cell Tumor Progression in Transgenic Mice

Ponikwicka-Tyszko, D; Chrusciel, M; Pulawska, K; Bernaczyk, P; Sztachelska, M; Guo, PL; Li, XD; Toppari, J; Huhtaniemi, IT; Wolczynski, S; Rahman, NA

Rahman, NA (corresponding author), Univ Turku, Inst Biomed, Res Ctr Integrat Physiol & Pharmacol, Turku 20520, Finland.; Rahman, NA (corresponding author), Med Univ Bialystok, Dept Reprod & Gynecol Endocrinol, PL-15276 Bialystok, Poland.

CANCERS, 2020; 12 (11):

Abstract

Simple Summary Recently, the antiprogestin activity of selective progesterone receptor (PR) modulator mifepristone (MF) has proven unsuccessful as a p......

Full Text Link